Neuregulin-1β1 rapidly modulates nitric oxide synthesis and calcium handling in rat cardiomyocytes

Cardiovascular Research

Volumn 88, Issue 3, 2010, Pages 443-452

  Brero, Alessia ^a   Ramella, Roberta ^a   Fitou, Amandine ^a   Dati, Claudio ^a   Alloatti, Giuseppe ^a   Gallo, Maria Pia ^a   Levi, Renzo ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Calcium handling; Cardiomyocyte; ErbB; Neuregulin; Nitric oxide

Indexed keywords

CALCIUM; CYCLIC GMP DEPENDENT PROTEIN KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NEU DIFFERENTIATION FACTOR; NEUREGULIN 1BETA1; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLAMBAN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; WORTMANNIN; ANDROSTANE DERIVATIVE; CALCIUM BINDING PROTEIN; DT 2 COMPOUND; DT-2 COMPOUND; FLUORESCEIN DERIVATIVE; NEUREGULIN BETA; NITRIC OXIDE; PEPTIDE FRAGMENT; PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; CONFOCAL MICROSCOPY; ELECTROPHYSIOLOGY; ENZYME PHOSPHORYLATION; HEART MUSCLE CELL; HEART PROTECTION; IMMUNOFLUORESCENCE; ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SARCOPLASMIC RETICULUM; WESTERN BLOTTING; ANIMAL; ANIMAL MODEL; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; METABOLISM; RAT STRAIN;

ANDROSTADIENES; ANIMALS; CALCIUM; CALCIUM-BINDING PROTEINS; CYCLIC GMP-DEPENDENT PROTEIN KINASES; FEMALE; FLUORESCEINS; MODELS, ANIMAL; MYOCYTES, CARDIAC; NEUREGULIN-1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDE FRAGMENTS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE INHIBITORS; RATS; RATS, INBRED STRAINS; SARCOPLASMIC RETICULUM;

EID: 78149338262     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq238     Document Type: Article

References (47)

1. Meyer D, Birchmeier C. Multiple essential functions of neuregulin in development. Nature 1995;378:386-390.
2. Lee KF, Simon H, Chen H, Bates B, Hung MC, Hauser C. Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 1995;378:394-398.
3. Gassmann M, Casagranda F, Orioli D, Simon H, Lai C, Klein R et al. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 1995; 378:390-394.
4. Guglin M, Cutro R, Mishkin JD. Trastuzumab-induced cardiomyopathy. J Card Fall 2008;14:437-444.
5. Ozcelik C, Erdmann B, Pilz B, Wettschureck N, Britsch S, Hubner N et al. Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy. Proc Natl Acad Sci USA 2002;99:8880-8885.
6. Garcia-Rivello H, Taranda J, Said M, Cabeza-Meckert P, Vila-Petroff M, Scaglione J et al. Dilated cardiomyopathy in Erb-b4-deficient ventricular muscle. Am J Physiol Heart Grc Physiol 2005;289:H1153-1160.
7. Zhao YY, Sawyer DR, Baliga RR, Opel DJ, Han X, Marchionni MA et al. Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes. J Biol Chem 1998;273: 10261-10269.
8. Cote GM, Miller TA, Lebrasseur NK, Kuramochi Y, Sawyer DB. Neuregulin-1 a: and (5 isoform expression in cardiac microvascular endothelial cells and function in cardiac myocytes in vitro. Exp Cell Res 2005;311:135-146.
9. Lemmens K, Segers VF, Demolder M, De Keulenaer GW. Role of neuregulin-1/ErbB2 signaling in endothelium-cardiomyocyte cross-talk. J Biol Chem 2006;281: 19469-19477.
10. Zhao YY, Feron O, Dessy C, Han X, Marchionni MA, Kelly RA. Neuregulin signaling in the heart. Dynamic targeting of erbB4 to caveolar microdomains in cardiac myocytes. Grc Res 1999;84:1380-1387.
11. Ueda H, Oikawa A, Nakamura A, Terasawa F, Kawagishi K, Moriizumi T. Neuregulin receptor ErbB2 localization at T-tubule in cardiac and skeletal muscle. J Histochem Cytochem 2005;53:87-91.
12. S6K, and MEK-MAPK-RSK Am j Physiol 1999;277:H2026-2037.
13. Sawyer DB, Zuppinger C, Miller TA, Eppenberger HM, Suter TM. Modulation of anthracycline-induced myofibrillar disarray in rat ventricular myocytes by neuregulin-1/3 and anti-erbB2: potential mechanism for trastuzumab-induced cardio-toxicity. Circulation 2002;105:1551-1554.
14. Kuramochi Y, Guo X, Sawyer DB. Neuregulin activates erbB2-dependent src/FAK signaling and cytoskeletal remodeling in isolated adult rat cardiac myocytes. J Mol Cell Cardiol 2006;41:228-235.
15. Fukazawa R, Miller TA, Kuramochi Y, Frantz S, Kim YD, Marchionni MA et al. Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt. j Mol Cell Cardiol 2003;35: 1473-1479.
16. Kuramochi Y, Cote GM, Guo X, Lebrasseur NK, Cui L, Liao R et al. Cardiac endothelial cells regulate reactive oxygen species-induced cardiomyocyte apoptosis through neuregulin-1 /3/erbB4 signaling.,/ Biol Chem 2004;279:51141-51147.
17. Timolati F, Ott D, Pentassuglia L, Giraud MN, Perriard JC, Suter TM et al. Neuregulin-1 beta attenuates doxorubicin-induced alterations of excitation-contraction coupling and reduces oxidative stress in adult rat cardiomyocytes. J Mol Cell Cardiol 2006;41:845-854.
18. Pentassuglia L, Timolati F, Seifriz F, Abudukadier K, Suter TM, Zuppinger C. Inhibition of ErbB2/neuregulin signaling augments paclitaxel-induced cardiotoxicity in adult ventricular myocytes. Exp Cell Res 2007;313:1588-1601.
19. Giraud MN, Fluck M, Zuppinger C, Suter TM. Expressional reprogramming of survival pathways in rat cardiocytes by neuregulin-1 /3. J Appl Physiol 2005;99: 313-322.
20. Jamnicki-Abegg M, Weihrauch D, Pagel PS, Kersten JR, Bosnjak ZJ, Warltier DC et al. Isoflurane inhibits cardiac myocyte apoptosis during oxidative and inflammatory stress by activating Akt and enhancing Bcl-2 expression. Anesthesiology 2005;103: 1006-1014.
21. Rohrbach S, Muller-Werdan U, Werdan K, Koch S, Gellerich NF, HoltzJ. Apoptosis-modulating interaction of the neuregulin/erbB pathway with anthracyclines in regulating Bcl-xS and Bcl-xL in cardiomyocytes. j Mol Cell Cardiol 2005;38:485-493.
22. Grazette LP, Boecker W, Matsui T, Semigran M, Force TL, Hajjar RJ et al. Inhibition of ErbB2 causes mitochondrial dysfunction in cardiomyocytes: implications for herceptin-induced cardiomyopathy, j Am Coll Cardiol 2004;44:2231-2238.
23. Pentassuglia L, Sawyer DB. The role of Neuregulin-1 /3/ErbB signaling in the heart. Exp Cell Res 2008;315:627-637.
24. Mautino B, Dalla Costa L, Gambarotta G, Perroteau I, Fasolo A, Dati C. Bioactive recombinant neuregulin-1,-2, and-3 expressed in Escherichia coli. Protein Expr Purif 2004;35:25-31.
25. Gallo MP, Levi R, Ramella R, Brero A, Boero O, Tota B et al. Endothelium-derived nitric oxide mediates the antiadrenergic effect of human vasostatin-1 in rat ventricular myocardium. Am j Physiol Heart Grc Physiol 2007;292:H2906-2912.
26. Gallo MP, Ramella R, Alloatti G, Penna C, Pagliaro P, Marcantoni A et al. Limited plasticity of mesenchymal stem cells cocultured with adult cardiomyocytes. J Cell Biochem 2007;100:86-99.
27. Lemmens K, Fransen P, Sys SU, Brutsaert DL, De Keulenaer GW. Neuregulin-1 induces a negative inotropic effect in cardiac muscle: role of nitric oxide synthase. Circulation 2004;109:324-326.
28. Ji L, Fu F, Zhang L, Liu W, Cai X, Zhang L et al. Insulin attenuates myocardial ischemia/ reperfusion injury via reducing oxi dative/nit rati ve stress. Am J Physiol Endocrinol Metab 2010;298:E871-880.
29. Gao F, Gao E, Yue TL, Ohlstein EH, Lopez BL, Christopher TA et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 2002;105:1497-1502.
30. Jonassen AK, Sack MN, Mjos OD, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Grc Res 2001;89:1191-1198.
31. Seidler T, Hasenfuss G, Maier LS. Targeting altered calcium physiology in the heart translational approaches to excitation, contraction, and transcription. Physiology (Bethesda) 2007;22:328-334.
32. Burley DS, Ferdinandy P, Baxter GF. Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling. Br J Pharmacol 2007;152:855-869.
33. Taylor MS, Okwuchukwuasanya C, Nickl CK, Tegge W, Brayden JE, Dostmann WR. Inhibition of cGMP-dependent protein kinase by the cell-permeable peptide DT-2 reveals a novel mechanism of vasoregulation. Mol Pharmacol 2004;65:1111-1119.
34. Hartell NA, Archer HE, Bailey CJ. Insulin-stimulated endothelial nitric oxide release is calcium independent and mediated via protein kinase B. Biochem Pharmacol 2005;69: 781-790.
35. + storage. Cardiovasc Res 2006;70:346-353.
36. Xu Z, Park SS, Mueller RA, Bagnell RC, Patterson C, Boysen PG. Adenosine produces nitric oxide and prevents mitochondrial oxidant damage in rat cardiomyocytes. Cardiovasc Res 2005;65:803-812.
37. Seddon M, Shah AM, Casadei B. Cardiomyocytes as effectors of nitric oxide signalling. Cardiovasc Res 2007;75:315-326.
38. Umar S, van der Laarse A. Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart. Mol Cell Biochem 2010;333:191-201.
39. Zhu M, Feng J, Lucchinetti E, Fischer G, Xu L, Pedrazzini T et al. Ischemic postcondi-tioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway. Cardiovasc Res 2006;72:152-162.
40. Gao F, Gao E, Yue TL, Ohlstein EH, Lopez BL, Christopher TA et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 2002;105:1497-1502.
41. Bell RM, Yellon DM. Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS. J Mol Cell Cardiol 2003; 35:185-193.
42. Crone SA, Zhao YY, Fan L, Gu Y, Minamisawa S, Liu Y et al. ErbB2 is essential in the prevention of dilated cardiomyopathy. Not Med 2002;8:459-465.
43. Sabine B, Willenbrock R, Haase H, Karczewski P, Wallukat G, Dietz R et al. Cyclic GMP-mediated phospholamban phosphorylation in intact cardiomyocytes. 8/ochem Biophys Res Commun 1995;214:75-80.
44. Raeymaekers L, Hofmann F, Casteels R. Cyclic GMP-dependent protein kinase phos-phorylates phospholamban in isolated sarcoplasmic reticulum from cardiac and smooth muscle. Biochem J 1998;252:269-273.
45. Zhang Q, Scholz PM, He Y, Tse J, Weiss HR. Cyclic GMP signaling and regulation of SERCA activity during cardiac myocyte contraction. Cell Calcium 2005;37:259-266.
46. Garcia-Dorado D, Agullo L, Sartorio CL, Ruiz-Meana M. Myocardial protection against reperfusion injury: the cGMP pathway. Thromb Haemost 2009; 101:635-642.
47. Abdallah Y, Gkatzoflia A, Pieper H, Zoga E, Walther S, Kasseckert S et al. Mechanism of cGMP-mediated protection in a cellular model of myocardial reperfusion injury. Cardiovasc Res 2005;66:123-131.